Decline In Ad Letters Does Not Signal Leniency By FDA, Agency Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is using warning letters to "presage," not "replace" enforcement action, Associate Commissioner Pitts tells DTC National Conference in Boston.